Form EFFECT Nasus Pharma Ltd
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 11, 2026 4:15 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ScriptSafe Launches Payment Certification for Pharmacies, With Online Advertising Certification Coming Next
- Silver Bow Mining Signs Term Sheet with Ocean Partners for Potential US$88 Million Funding and Credit Support Package and Ten-Year Zinc and Lead Concentrate Offtake Agreements
- The More Life Company Reports Rapid Systemic Delivery of USP Testosterone in Exploratory Quicksome™ Study
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
